Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modufolin in metastatic colorectal cancer
NCT02244632Phase 2Completed
- Sponsor
- Isofol Medical
- Start
- Sep 2014
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of arfolitixorin in metastatic colorectal cancer (mCRC), sponsored by Isofol Medical. Started Sep 2014; status: completed.
02
Drugs
arfolitixorin
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02244632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244632.